H-alpha-Me-L-Phe(4-Br)-OH

H-alpha-Me-L-Phe(4-Br)-OH is an L-phenylalanine-derived amino acid derivative bearing an alpha-methyl substituent and a para-bromo substituent on the aromatic ring, with the amino acid framework retaining an aniline-like phenyl side chain substituted at the 4-position. The molecule contains a free primary amino group and a free carboxylic acid, and its steric and electronic profile is modulated by the alpha-Me group and the aryl bromine, which can influence conformational preferences and side-chain reactivity in peptide-related chemistry. In synthesis and chemical biology workflows, this compound is used as a building block for preparing modified peptides or peptide analogues and for structure-activity or labeling studies where a brominated aromatic handle and an alpha-methyl stereochemical perturbation are required.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP26026

CAS No:747397-27-9

Synonyms/Alias:H-alpha-Me-L-Phe(4-Br)-OH;747397-27-9;(S)-ALPHA-METHYL-4-BROMOPHENYLALANINE;AmbotzHAA5470;CTK8F0549;H-A-ME-PHE(4-BR)-OH;MolPort-000-001-118;9202AH;ZINC36914685;(S)-alpha-Mmethyl-4-bromophenylalanine;AB48912;(S)-A-METHYL-4-BROMOPHENYLALANINE;RT-013187;L-PHENYLALANINE,4-BROMO-ALPHA-METHYL;(2S)-2-AMINO-3-(4-BROMOPHENYL)-2-METHYLPROPANOICACID

Chemical Name:(S)-a-Methyl-4-bromophenylalanine (>98%, >98%ee)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C10H12BrNO2
M.W/Mr.
258.11
Application
Nucleotides synthesis; drug screening

H-alpha-Me-L-Phe(4-Br)-OH is an L-phenylalanine derivative bearing an alpha-methyl substituent (H-alpha-Me) and a para-bromo substituent on the aromatic ring, with a free carboxylic acid and an unprotected amino functionality implied by the name's amino acid format. The stereogenic alpha carbon created by the alpha-methyl group enforces defined chiral geometry for peptide coupling and for downstream stereochemical retention or controlled epimerization strategies. The para-bromophenyl side chain introduces a halogen handle that can participate in cross-coupling chemistry, while the aromatic ring supports hydrophobic and π-interaction motifs relevant to peptide analog design. The combination of a chiral, functionalized amino acid backbone with a reactive aryl bromide makes the compound a practical intermediate for amino acid derivatization and for constructing brominated phenylalanine-containing peptide building blocks.

1. Peptide Synthesis

H-alpha-Me-L-Phe(4-Br)-OH is suitable for peptide building block workflows in solid-phase or solution-phase peptide synthesis where the L-configuration and alpha-methyl stereocenter can be preserved through standard coupling conditions. The free carboxylic acid and amino functionality enable formation of amide bonds after appropriate temporary protection of the amine and, when needed, activation of the acid for coupling. The para-bromo substituent on the side-chain phenyl ring can be carried through peptide assembly and later used for late-stage diversification via arylation or cross-coupling, supporting structure-activity relationship (SAR) focused analog generation. Incorporation of alpha-methyl phenylalanine into peptides can also modulate conformational preferences, which is useful when designing peptides and peptidomimetics with altered backbone dynamics. H-alpha-Me-L-Phe(4-Br)-OH thus functions as a chiral, halogenated amino acid intermediate for constructing brominated peptide analogs and related research-grade sequences.

2. Side-Chain Functionalization

H-alpha-Me-L-Phe(4-Br)-OH is well aligned with medicinal chemistry and chemical biology programs that require side-chain functionalization from an aryl bromide starting point. The para-bromo group on the phenyl ring provides a direct electrophilic site for palladium-catalyzed cross-coupling reactions, enabling installation of aryl, heteroaryl, or substituted motifs without changing the amino acid backbone. The alpha-methyl stereochemistry supports stereodefined analog series, allowing systematic exploration of how steric effects at the alpha position influence binding or stability in peptide-derived scaffolds. The retained carboxylic acid enables conversion to esters or activated derivatives for conjugation or for preparing protected amino acid forms used in iterative synthesis. H-alpha-Me-L-Phe(4-Br)-OH therefore supports amino acid derivatization strategies that connect chiral building block preparation to late-stage molecular diversification.

3. Chiral Building Block Development

H-alpha-Me-L-Phe(4-Br)-OH is used as a chiral amino acid intermediate for preparing stereochemically defined derivatives where the alpha-methyl center serves as a stereochemical control element. The L-configuration combined with the alpha-methyl substituent can be leveraged to access conformationally constrained analogs and to generate defined stereoisomer series for method development and stereochemical studies. The carboxylic acid can be transformed into protected amino acid derivatives or activated intermediates, while the aromatic bromide can remain intact to support orthogonal functionalization steps later in a synthetic sequence. Protecting-group strategies commonly applied to amino acid chemistry, such as amine protection and selective esterification, can be used to manage chemoselectivity during multi-step syntheses that include coupling and subsequent aryl modification. H-alpha-Me-L-Phe(4-Br)-OH thus functions as a chiral precursor for stereodefined amino acid derivatives and peptide-relevant intermediates used in synthetic organic chemistry.

4. Peptidomimetics And SAR Studies

H-alpha-Me-L-Phe(4-Br)-OH is applicable to peptidomimetic construction and SAR studies where alpha-methylation and para-halogenation are used to tune physicochemical and structural properties of peptide-like scaffolds. The alpha-methyl group can influence backbone torsion and resistance to proteolytic degradation when incorporated into peptide analogs, while the para-bromophenyl side chain provides a handle for generating analog libraries through aryl substitution patterns. The free carboxylic acid supports conversion to coupling-ready forms, enabling systematic synthesis of amide-linked analogs that preserve the intended stereochemistry at the alpha center. The aromatic bromide can be exploited for diversification after scaffold assembly, supporting iterative SAR workflows that compare substituent effects on binding-relevant interactions. H-alpha-Me-L-Phe(4-Br)-OH therefore serves as a chiral, halogenated amino acid scaffold component for generating structured analog sets in medicinal chemistry and chemical biology research.

5. Pharmaceutical Intermediate Preparation

H-alpha-Me-L-Phe(4-Br)-OH is relevant to pharmaceutical intermediate preparation and specialty chemical production where halogenated amino acid derivatives are used as feedstocks for downstream synthesis of complex, functionalized molecules. The amino acid backbone enables conversion into protected amino acid derivatives and activated intermediates required for controlled amide bond formation in multi-step manufacturing routes. The para-bromo substituent can be retained as a reactive intermediate for later cross-coupling steps, allowing manufacturing processes to postpone diversification until later stages and to reduce the number of distinct early-stage intermediates. The defined stereochemistry at the alpha position supports consistent quality in chiral synthesis workflows that require stereochemical integrity across batch operations. H-alpha-Me-L-Phe(4-Br)-OH thus functions as a process-compatible chiral amino acid intermediate for producing brominated building blocks used in fine chemical and pharmaceutical-related synthesis.

6. Chemical Manufacturing And Process Chemistry

H-alpha-Me-L-Phe(4-Br)-OH can be employed in process chemistry for the manufacture of chiral, halogenated amino acid derivatives that serve as intermediates in peptide construction and diversified small-molecule synthesis. The presence of a carboxylic acid enables straightforward conversion to salts, esters, or activated coupling partners, while the aromatic bromide provides a chemoselective handle for controlled downstream transformations under cross-coupling conditions. The alpha-methyl stereocenter supports route design that accounts for stereochemical preservation, with protecting-group selection enabling orthogonal reactivity management between amine protection, acid activation, and later aryl functionalization. The compound's defined L-stereochemistry makes it suitable for stereochemically consistent intermediate preparation that feeds into broader manufacturing sequences for amino acid-based products. H-alpha-Me-L-Phe(4-Br)-OH therefore supports industrially relevant amino acid derivative synthesis where chiral control and functional group orthogonality are central to reliable downstream conversion.

Size
1 g;
InChI
1S/C10H12BrNO2/c1-10(12,9(13)14)6-7-2-4-8(11)5-3-7/h2-5H,6,12H2,1H3,(H,13,14)/t10-/m0/s1
InChI Key
PEGRPUVDOKWERK-JTQLQIEISA-N
Canonical SMILES
CC(CC1=CC=C(C=C1)Br)(C(=O)O)N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Synthesis ServicesEpitope Mapping ServicescGMP Peptide ServiceCustom Conjugation ServicePeptide Modification ServicesPeptide Nucleic Acids SynthesisPeptide Analysis ServicesPeptide CDMO
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers